SPOTLIGHT -
Therapeutic successes and a trend toward delaying childbearing now permit survivors of breast, ovarian, endometrial, and cervical cancers to consider future fertility. How should this affect the advice you offer your patients?
FDA approves gepotidacin for uncomplicated UTI treatment
The approval marks a vital step toward care for urinary tract infections, helping to reduce recurrence and improve patients’ quality of life.
Read More
Contemporary OB/GYN week in review: Chronic pain, abortion laws, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: The Revi System, sleep health, and more
Contemporary OB/GYN week in review: breast cancer screening, UUI management, and more
Survey highlights postpartum incontinence struggles and lack of medical support
A survey by Aeroflow Urology finds many mothers face postpartum incontinence without medical support, impacting their health, stress, and daily life.
Revi System demonstrates positive two-year results for treating urgency urinary incontinence
BlueWind Medical’s Revi System shows strong two-year efficacy and safety for UUI, with symptom reduction and high patient satisfaction.